Cargando…
Pyruvate kinase L/R links metabolism dysfunction to neuroendocrine differentiation of prostate cancer by ZBTB10 deficiency
Neuroendocrine differentiation (NED) frequently occurs in androgen-deprivation therapy (ADT)-resistant prostate cancer (PCa) and is typically associated with metabolic pathway alterations, acquisition of lineage plasticity, and malignancy. There is no conventional therapeutic approach for PCa patien...
Autores principales: | Wen, Yu-Ching, Chen, Wei-Yu, Tram, Van Thi Ngoc, Yeh, Hsiu-Lien, Chen, Wei-Hao, Jiang, Kuo-Ching, Abou-Kheir, Wassim, Huang, Jiaoti, Hsiao, Michael, Liu, Yen-Nien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934352/ https://www.ncbi.nlm.nih.gov/pubmed/35306527 http://dx.doi.org/10.1038/s41419-022-04694-z |
Ejemplares similares
-
CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer
por: Wen, Yu-Ching, et al.
Publicado: (2023) -
TCF7L1 regulates cytokine response and neuroendocrine differentiation of prostate cancer
por: Wen, Yu-Ching, et al.
Publicado: (2021) -
Nerve growth factor interacts with CHRM4 and promotes neuroendocrine differentiation of prostate cancer and castration resistance
por: Chen, Wei-Yu, et al.
Publicado: (2021) -
Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer
por: Tsai, Yuan-Chin, et al.
Publicado: (2018) -
MicroRNA-34a regulates WNT/TCF7 signaling and inhibits bone metastasis in Ras-activated prostate cancer
por: Chen, Wei-Yu, et al.
Publicado: (2014)